Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CardIQ Suite

K-Number: K213725 · 2022-03-11

Decision Date2022-03-11
Product CodeJAK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

CardIQ Suite is a medical device manufactured by GE Medical Systems SCS. It received FDA 510(k) clearance on 2022-03-11 under approval number K213725. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CardIQ Suite?

CardIQ Suite is a medical device that received FDA 510(k) clearance on 2022-03-11. It is manufactured by GE Medical Systems SCS. The 510(k) number is K213725.

When was CardIQ Suite approved by the FDA?

CardIQ Suite received FDA 510(k) clearance on 2022-03-11, under approval number K213725.

What company makes CardIQ Suite?

CardIQ Suite is manufactured by GE Medical Systems SCS.

What is the FDA product code for CardIQ Suite?

The FDA product code for CardIQ Suite is JAK.

Other Devices by GE Medical Systems SCS

View all 27 devices →

Related Devices (Code: JAK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.